CervoMed Inc. (CRVO) Corporate Subsidiaries
CervoMed Inc. (CRVO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRVO
CIK: 1053691
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerKaitlin Folinus
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | FORM 8-K | 0001437749-26-032620 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-12 | FORM 8-K | 0001437749-26-032502 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-09 | FORM 8-K | 0001437749-26-032445 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | FORM 8-K | 0001437749-26-031389 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | FORM 8-K | 0001437749-26-030073 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000921 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001649553-26-000101 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000919574-26-005262 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003567 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | FORM 8-K | 0001437749-26-026771 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | FORM S-8 | 0001437749-26-026605 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | FORM 10-Q | 0001437749-26-026592 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | FORM 8-K | 0001437749-26-025509 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | FORM 8-K | 0001437749-26-023538 | View SEC Doc Filr Page |
| EFFECT | 2026-07-10 | — | EFFECT Filing | 9999999995-26-002264 | View SEC Doc Filr Page |
| 424B3 | 2026-07-10 | — | FORM 424B3 | 0001437749-26-023357 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-09 | FORM 8-K | 0001437749-26-023200 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0000895421-26-000201 | View SEC Doc Filr Page |
| S-3 | 2026-07-06 | — | FORM S-3 | 0001437749-26-022812 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-26 | — | SCHEDULE 13G Filing | 0001649553-26-000070 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-22 | FORM 8-K | 0001437749-26-021309 | View SEC Doc Filr Page |
| 424B5 | 2026-06-22 | — | FORM 424B5 | 0001437749-26-021218 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | FORM 8-K | 0001437749-26-021208 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-16 | FORM 8-K | 0001437749-26-021038 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-15 | — | SCHEDULE 13D/A Filing | 0001437749-26-020692 | View SEC Doc Filr Page |